In the world of medical treatment and weight loss management, the use of GLP-1 (Glucagon-Like Peptide-1) agonists has become increasingly prominent. However, a crucial issue arises with the current standard for prescribing these treatments, primarily based on Body...
$1.67 trillion per year GLP 1 Dilemma: Why BMI is Not the Right Criteria for Weight Loss Prescription
read more